UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 129

Sortiert nach

Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials

British journal of dermatology (1951), 2008-09, Vol.159 (3), p.513-526

2008

Volltextzugriff (PDF)

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

British journal of dermatology (1951), 2011-11, Vol.165 (5), p.1109-1117

2011

Volltextzugriff (PDF)

Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2)

British journal of dermatology (1951), 2013-06, Vol.168 (6), p.1325-1334

2013

Volltextzugriff (PDF)

Up‐regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid

Clinical and experimental immunology, 2011-11, Vol.166 (2), p.145-153

2011

Volltextzugriff (PDF)

A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of psoriasis vulgaris

British journal of dermatology (1951), 2006-06, Vol.154 (6), p.1155-1160

2006

Volltextzugriff (PDF)

A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet((R))/Daivobet((R))/Taclonex((R))) in the treatment of psoriasis vulgaris

British journal of dermatology (1951), 2006-06, Vol.154 (6), p.1155

2006

Volltextzugriff (PDF)

Scalp psoriasis: a review of current topical treatment options

Journal of the European Academy of Dermatology and Venereology, 2007-10, Vol.21 (9), p.1151-1160

2007

Volltextzugriff (PDF)

Evaluation of methylprednisolone aceponate, tacrolimus and combination thereof in the psoriasis plaque test using sum score, 20-MHz-ultrasonography and optical coherence tomography

International journal of clinical pharmacology and therapeutics, 2010-12, Vol.48 (12), p.814

2010

Volltextzugriff (PDF)

The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis

Dermatology (Basel), 2005-01, Vol.210 (3), p.194

2005

Volltextzugriff (PDF)

FRI0488 Analysis of REAL Life Vasoactive Therapy in over 3000 Patients with Systemic Sclerosis (SSC) Reveals Considerable Undertreatment and Significant Changes of Treatment Practice since 2004

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.564-564

2014

Volltextzugriff (PDF)

Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris

British journal of dermatology (1951), 2004-06, Vol.150 (6), p.1167-1173

2004

Volltextzugriff (PDF)

SAT0209 The Risk for Initial Digital Ulcer Involvement in SSC Patients Decreases with Disease Duration Since the Beginning of Raynaud Phenomenon

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A651-A651

2013

Volltextzugriff (PDF)

SAT0191 Disease Progression in SSC-Overlap Syndromes is Significantly Different from Limited and Diffuse Cutaneous SSC

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A645-A646

2013

Volltextzugriff (PDF)

Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris

Dermatology (Basel), 2006-11, Vol.213 (4), p.319

2006

Volltextzugriff (PDF)

Hypersensitivity reactions to dapsone: a systematic review

Acta dermato-venereologica, 2012-01, Vol.92 (2), p.194-199

2012

Volltextzugriff (PDF)

Leflunomide as a novel treatment option in severe atopic dermatitis

British journal of dermatology (1951), 2004-06, Vol.150 (6), p.1182-1185

2004

Volltextzugriff (PDF)

Dapsone and sulfones in dermatology: Overview and update

Journal of the American Academy of Dermatology, 2003-02, Vol.48 (2), p.308-309

2003

Volltextzugriff (PDF)

Granuloma anulare giganteum et disseminatum

Aktuelle Dermatologie, 2011-06, Vol.37 (6), p.210-213

2011

Volltextzugriff (PDF)

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

The Lancet (British edition), 2008-05, Vol.371 (9625), p.1675-1684

2008

Volltextzugriff (PDF)

Eosinophile Dermatosen

Hautarzt, 2007-04, Vol.58 (4), p.347-360

WOZEL, G

2007

Volltextzugriff (PDF)

Prospective study in bullous pemphigoid: association of high serum anti‐BP180 IgG levels with increased mortality and reduced Karnofsky score

British journal of dermatology (1951), 2018-10, Vol.179 (4), p.918-924

2018

Volltextzugriff (PDF)

Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab

Acta dermatovenerologica Alpina, Panonica, et Adriatica, 2008-09, Vol.17 (3), p.133-136

2008

Volltextzugriff (PDF)

Effectiveness of interdisciplinary vs. dermatological care of moderate-to-severe psoriasis: a pragmatic randomised controlled trial

Acta dermato-venereologica, 2014-01, Vol.94 (2), p.192-197

2014

Volltextzugriff (PDF)

Therapeutic strategies for psoriasis and psoriatic arthritis

Hautarzt, 2009-02, Vol.60 (2), p.91

Wozel, G

2009

Volltextzugriff (PDF)

Dapsone-induced photodermatitis in a patient with linear IgA dermatosis

EJD. European journal of dermatology, 2001, Vol.11 (1), p.50-53

2001

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(65)
Deutsch
(63)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(80)
Life Sciences & Biomedicine
(51)
Science & Technology
(51)
Female
(49)
Dermatology
(45)
Middle Aged
(34)
Adult
(30)
Male
(30)
Biological And Medical Sciences
(29)
Medical Sciences
(28)
Psoriasis - Drug Therapy
(27)
Aged
(21)
Treatment Outcome
(20)
Psoriasis
(19)
Pharmacology. Drug Treatments
(12)
Adolescent
(11)
Dermatologic Agents - Administration & Dosage
(11)
Double-Blind Method
(11)
Psoriasis. Parapsoriasis. Lichen
(11)
Dose-Response Relationship, Drug
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2)

Up‐regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid

A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of psoriasis vulgaris

A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet((R))/Daivobet((R))/Taclonex((R))) in the treatment of psoriasis vulgaris

Scalp psoriasis: a review of current topical treatment options

Evaluation of methylprednisolone aceponate, tacrolimus and combination thereof in the psoriasis plaque test using sum score, 20-MHz-ultrasonography and optical coherence tomography

The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis

FRI0488 Analysis of REAL Life Vasoactive Therapy in over 3000 Patients with Systemic Sclerosis (SSC) Reveals Considerable Undertreatment and Significant Changes of Treatment Practice since 2004

Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris

SAT0209 The Risk for Initial Digital Ulcer Involvement in SSC Patients Decreases with Disease Duration Since the Beginning of Raynaud Phenomenon

SAT0191 Disease Progression in SSC-Overlap Syndromes is Significantly Different from Limited and Diffuse Cutaneous SSC

Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris

Hypersensitivity reactions to dapsone: a systematic review

Leflunomide as a novel treatment option in severe atopic dermatitis

Dapsone and sulfones in dermatology: Overview and update

Granuloma anulare giganteum et disseminatum

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Eosinophile Dermatosen

Prospective study in bullous pemphigoid: association of high serum anti‐BP180 IgG levels with increased mortality and reduced Karnofsky score

Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab

Effectiveness of interdisciplinary vs. dermatological care of moderate-to-severe psoriasis: a pragmatic randomised controlled trial

Therapeutic strategies for psoriasis and psoriatic arthritis

Dapsone-induced photodermatitis in a patient with linear IgA dermatosis

Suchergebnisse filtern